论文信息 - Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC) - 字舞流文

Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC)

S. Chia | V. Borges | S. Moulder | T. Baetz | R. Murthy | T. Mcspadden | Gina Fernetich | R. Chavira | K. Guthrie | E. Barrett | G. Fernetich